Monday, June 29

● Latest

Economy Turkey's Economic Bet on a Fractured Iran Tech Tidal Cuts Off Royalties for AI-Generated Music but Won't Ban It Markets Why Value Stocks Tend to Beat Growth When Inflation Runs Hot Personal Finance Big Health Costs Your Insurance Probably Won't Cover, and How to Plan for Them Economy Solar Outproduced Coal in the US in April. The Catch Is in the Fine Print Companies AeroVironment Tops Estimates as Demand for Combat Drones Surges Personal Finance The IRS Clears a Gift-Tax Worry for the New Trump Accounts. What to Know Companies Inside the FDA's PreCheck Push to Bring Drug Manufacturing Back to the US Economy Turkey's Economic Bet on a Fractured Iran Tech Tidal Cuts Off Royalties for AI-Generated Music but Won't Ban It Markets Why Value Stocks Tend to Beat Growth When Inflation Runs Hot Personal Finance Big Health Costs Your Insurance Probably Won't Cover, and How to Plan for Them Economy Solar Outproduced Coal in the US in April. The Catch Is in the Fine Print Companies AeroVironment Tops Estimates as Demand for Combat Drones Surges Personal Finance The IRS Clears a Gift-Tax Worry for the New Trump Accounts. What to Know Companies Inside the FDA's PreCheck Push to Bring Drug Manufacturing Back to the US

Topic: reshoring

Pharmaceutical drug research at a laboratory

Monday, 6/29, 07:43 PM

Inside the FDA's PreCheck Push to Bring Drug Manufacturing Back to the US

The FDA's new 'PreCheck' program aims to speed approvals for new US drug factories, part of a broader effort to reshore pharmaceutical production from Asia.
Eli Lilly and Regeneron — two of the biggest spenders on new American plants — are among those reported to be in the first group.

reshoring — news and stories on this topic

This page collects all of Boursel's coverage of reshoring. Follow the topic from one place: new stories appear here automatically as more is published. That way you stay on top of how the situation develops.

Looking for the bigger picture? Browse markets, the economy, companies and crypto, or head back to the front page for the day's top stories.